Evidence map›Paper›PMID 40871553›Full record

ArticleMolecules (Basel, Switzerland)2025

Design, Synthesis, and Pharmacological Activity of the

Lina Hu, Mengjiao Li, Zheng Liu, Hui Yan, Xuekun Wang, Shiben Wang

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lina HuState Key Laboratory of Macromolecular Drugs and Large-Scale Preparation, School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng 252059, China.
Mengjiao LiState Key Laboratory of Macromolecular Drugs and Large-Scale Preparation, School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng 252059, China.
Zheng LiuSchool of Medicine, Foshan University, Foshan 528000, China.
Hui YanState Key Laboratory of Macromolecular Drugs and Large-Scale Preparation, School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng 252059, China.ORCID 0000-0002-9843-0601
Xuekun WangState Key Laboratory of Macromolecular Drugs and Large-Scale Preparation, School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng 252059, China.
Shiben WangState Key Laboratory of Macromolecular Drugs and Large-Scale Preparation, School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng 252059, China.ORCID 0000-0002-8435-8135

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To discover novel, potent anticonvulsant compounds, a series of compounds containing triazole structural fragments were synthesized and evaluated for their anticonvulsant activity. Compounds

Indexed as

AmidesAnticonvulsantsDrug DesignTriazolesAnimalsAnti-Anxiety AgentsBinding SitesBrainElectroshockgamma-Aminobutyric AcidMaleMiceMolecular Docking SimulationMolecular StructurePentylenetetrazoleRatsAmidesAnti-Anxiety AgentsAnticonvulsantsgamma-Aminobutyric AcidPentylenetetrazoleReceptors, GABA-ATriazolesanticonvulsantGABAmolecular dockingsynthesistriazole

Identifiers

PMID40871553
PMCPMC12388125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.